Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases
Clinical trial NCT02758132 · TERMINATED
Trial details
- NCT number
- NCT02758132
- Sponsor
- University of Hawaii
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-09-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.